General MedicationsINJECTIONGeneric
TYMTRAN
CERULETIDE DIETHYLAMINE
Standard Dose
0.02MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TYMTRAN is listed in Drugs@FDA under application 018296 (NDA).
Marketing status: Discontinued Active ingredient CERULETIDE DIETHYLAMINE Form and strength INJECTABLE;INJECTION - 0.02MG/ML Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview TYMTRAN is listed in Drugs@FDA under application 018296 (NDA). Marketing status: Discontinued Active ingredient CERULETIDE DIETHYLAMINE Form and strength INJECTABLE;INJECTION - 0.02MG/ML Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.